R. D. Knihinicki, K. M. Williams and R. O. Day, “Chiral Inversion of 2-Arylpropionic Acid Non-Steroidal Anti- Inflammatory Drugs—I. In Vitro Studies of Ibuprofen and Flurbiprofen,” Biochemical Pharmacology, Vol. 38, No. 24, December 1989, pp. 4389-4395.
 S. M. Sanins, W. J. Adams, D. G. Kaiser, G. W. Halstead, J. Hosley, H. Barnes and T. A. Baillie, “Mechanistic Studies on the Metabolic Chiral Inversion of R-Ibuprofen in the Rat,” Drug Metabolism and Disposition, Vol. 19, No. 2, March-April 1991, pp. 405-410.
 J. Caldwell, A. J. Hull and S. Fournel-Gigleux, “The Metabolic Chiral Inversion and Dispositional Enantioselectivity of the 2-Arylpropionic Acids and their Biological Consequences,” Biochemical Pharmacology, Vol. 37, No. 1, January 1988, pp. 105-114.
 D. G. Kaiser, G. J. Van Giessen, R. J. Reischer and W. J. Wechter, “Isomeric Inversion of Ibuprofen (R)-Enantiomer in Humans,” Journal of Pharmaceutical Sciences, Vol. 65, No. 2, February 1976, pp. 269-273.
 T. A. Baillie, W. J. Adams, D. G. Kaiser, L. S. Olanoff, G. W. Halstead, H. Harpootlian and G. J. Van Giessen, “Mechanistic Studies of the Metabolic Chiral Inversion of (R)-Ibuprofen in Humans,” Journal of Pharmacology and Experimental Therapeutics, Vol. 249, No. 2, May 1989, pp. 517-523.
 S. S. Adams, P. Bresloff and C. G. Mason, “Pharmacological Differences Between Optical Isomers of Ibuprofen: Evidence for Metabolic Inversion of the (–)-Isomer,” Journal of Pharmacy and Pharmacology, Vol. 28, No. 3, March 1976, pp. 256-257.
 A. J. Hutt and J. Caldwell, “The Metabolic Chiral Inversion of 2-Aryl Propionic Acids—A Novel Route with Pharmacological Consequences,” Journal of Pharmacy and Pharmacology, Vol. 35, No. 11, November 1983, pp. 693-704.
 A. J. Hutt and J. Caldwell, “The Importance of Stereochemistry in the Clinical Pharmacokinetics of the 2- Arylpropionic Acid Non-Steroidal Anti-Inflammatory Drugs,” Clinical Pharmacokinetics, Vol. 9, No. 4, July- August 1984, pp. 371-373.
 S. C. Tan, B. K. Patel, S. H. D. Jackson, C. G. Swift, and J. Hutt, “Stereoselectivity of Ibuprofen Metabolism and Pharmacokinetics Following the Administration of the Racemate to Healthy Volunteers,” Xenobiotica, Vol. 32, No. 8, August 2002, pp. 683-697.
 E. J. Lee, K. Williams, R. Day, G. Graham and D. Champion, “Stereoselective Disposition of Ibuprofen Enantiomers in Man,” British Journal of Clinical Pharmacology, Vol. 19, No. 5, May 1985, pp. 669-674.
 S. C. Tan, B. K. Patel, S. H. Jackson, C. G. Swift and A. J. Hutt, “Influence of Age on the Enantiomeric Disposition of Ibuprofen in Healthy Volunteers,” British Journal of Clinical Pharmacology, Vol. 55, No. 6, June 2003, pp. 579-587.
 G. F. Lockwood, K. S. Albert, G. J. Szpunar and J. G. Wagner, “Pharmacokinetics of Ibuprofen in Man—III: Plasma Protein Binding,” Journal of Pharmacokinetics & Biopharmaceutics, Vol. 11, No. 5, October 1983, pp. 469-482.
 J. K. Paliwal, D. E Smith, S. R Cox, R. R Berardi, V. A. Dunn-Kucharski and G. H. Elta, “Stereoselective, Competitive, and Nonlinear Plasma Protein Binding of Ibuprofen Enantiomers as Determined in Vivo in Healthy Subjects,” Journal of Pharmacokinetics and Biopharmaceutics, Vol. 21, No. 2, April 1993, pp. 145-161.
 J. C. Nielsen, P. Bjerring, L. Arendt-Nielsen and K.-J. Petterson, “A Double-Blind, Placebo Controlled, Cross- over Comparison of the Analgesic Effect of Ibuprofen 400 Mg and 800 Mg on Laser-Induced Pain,” British Journal of Clinical Pharmacology, Vol. 30, No. 5, November 1990, pp. 711-715.
 S. Menzel-Soglowek, G. Geisslinger and K. Brune, “Stereoselective High-Performance Liquid Chromatographic Determination of Ketoprofen, Ibuprofen and Fenoprofen in Plasma Using a Chiral Alpha 1-Acid Glycoprotein Column,” Journal of Chromatography A, Vol. 532, No. 2, November 1990, pp. 295-303.
 K. J. Pettersson and A. Olsson, “Liquid Chromatographic Determination of The Enantiomers of Ibuprofen in Plasma Using a Chiral AGP Column,” Journal of Chromatography A, Vol. 563, No. 2, February 1991, pp. 414-418.
 W. Naidong and J. W. Lee, “Development and Validation of a Liquid Chromatographic Method for the Quantitation of Ibuprofen Enantiomers in Human Plasma,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 12, No. 4, April 1994, pp. 551-556.
 H. Y. Aboul-Enein, A. Van Overbeke, G. Vander Weken, W. Baeyens, H. Oda, P. Deprez and A. De Kruif, “HPLC on Chiralcel OJ-R for Enantiomer Separation and Analysis of Ketoprofen, from Horse Plasma, as the 9-Aminophenanthrene Derivative,” Journal of Pharmacy and Pharmacology, Vol. 50, No. 3, March 1998, pp. 291-296.
 K. Tachibana and A. Ohnishi, “Reversed-Phase Liquid Chromatographic Separation of Enantiomers on Polysaccharide Type Chiral Stationary Phases,” Journal of Chro- matography A, Vol. 906, No. 1-2, January 2001, pp. 127-154.
 X. W. Teng, S.W. Wang and N. M. Davies, “Stereospecific High-Performance Liquid Chromatographic Analysis of Ibuprofen in Rat Serum,” Journal of Chromatography B, Vol. 796, No. 2, November 2003, pp. 225-231.
 A. Reddy, M. Hashim, Z. Wang. L. Penn, C. J. Stankovic, D. Burdette, N. Surendran and H. Cai, “A Novel Method for Assessing Inhibition of Ibuprofen Chiral Inversion and its Application in Drug Discovery,” International Journal of Pharmaceutics, Vol. 335, No. 1-2, April 2007, pp. 63-69.
 P. S. Bonato, M. P. Del Lama and R. Carvalho, “Enantioselective Determination of Ibuprofen in Plasma by High-Performance Liquid Chromatography-Electrospray Mass Spectrometry,” Journal of Chromatography B, Vol. 796, No. 2, November 2003, pp. 413-420.
 E. J. D. Lee, K. M. Williams, G. G. Graham, R. O. Day, and G. D. Champion, “Liquid Chromatographic Determination and Plasma Concentration Profile of Optical Isomers of Ibuprofen in Humans,” Journal of Pharmaceutical Sciences, Vol. 73, No. 11, November 1984, pp. 1542-1544.
 C. H. Lemko, G. Caille and R. T. Foster, “Stereospecific High-Performance Liquid Chromatographic Assay of Ibuprofen: Improved Sensitivity and Sample Processing Efficiency,” Journal of Chromatography A, Vol. 619, No. 2, September 1993, pp. 330-335.
 S. C. Tan, S. H. D Jackson, C. G Swift and A. J. Hutt, “Enantiospecific Analysis of Ibuprofen by High Performance Liquid Chromatography: Determination of Free and Total Drug Enantiomer Concentrations in Serum and Urine,” Chromatographia, Vol. 46, No. 1-2, July 1997, pp. 23-32.
 M. J. Hilton and K. V. Thomas, “Determination of Selected Human Pharmaceutical Compounds in Effluent and Surface Water Samples by High-Performance Liquid Chromatography-Electrospray Tandem Mass Spectrometry,” Journal of Chromatography A, Vol. 1015, No. 1-2, October 2003, pp. 129-141.
 R. Leverence, M. J. Avery, O. Kavetskaia, H. Bi, C. E. Hop and A. I. Gusev, “Signal Suppression/Enhancement in HPLC-ESI-MS/MS from Concomitant Medications,” Biomedical Chromatography, Vol. 21, No. 11, November 2007, pp. 1143-1150.
 S. Y. Chang, W. Li, S. C. Traeger, B. Wang, D. Cui, H. Zhang, B. Wen and A.D. Rodrigues, “Confirmation that Cytochrome P450 2C8 (CYP2C8) Plays a Minor Role in (S)-(+)- and (R)-(-)-Ibuprofen Hydroxylation in Vitro,” Drug Metabolism and Disposition, Vol. 36, No. 12, December 2008, pp. 2513-2522.
 G. D. Mendes, F. D. Mendes, C. C. Domingues, R. A de Oliveira, M. A. da Silva, L. S. Chen, J. O. Ilha, C. E. Fernandes and G. De Nucci, “Comparative Bioavailability of Three Ibuprofen Formulations in Healthy Human Volunteers,” International Journal of Clinical Pharmacology and Therapeutics, Vol. 46, No. 6, June 2008, pp. 309- 318.
 P. Seideman, F. Lohrer, G. G. Graham, M. W. Duncan, K. M. Williams and R. O. Day, “The Stereoselective Disposition of the Enantiomers of Ibuprofen in Blood, Blister and Synovial Fluid,” British Journal of Clinical Pharmacology, Vol. 38, No. 3, September 1994, pp. 221-227.
 B. A. Way, T. R. Wilhite, C. H. Smith and M. Landt, “Measurement of Plasma Ibuprofen by Gas Chromatography-Mass Spectrometry,” Journal of Clinical Laboratory Analysis, Vol. 11, No. 6, April 1997, pp. 336-339.
 á. Seb?k, A. Vasanits-Zsigrai, Gy. Palkó, Gy. Záray and I. Molnár-Perl, “Identification and Quantification of Ibuprofen, Naproxen, Ketoprofen and Diclofenac Present in Waste-Waters, as their Trimethylsilyl Derivatives, by Gas Chromatography Mass Spectrometry,” Talanta, Vol. 76, No. 3, July 2008, pp. 642-650.